Colhoun HM - Search Results

1

Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.

Colhoun HM, Betteridge DJ, Durrington P, Hitman G, Neil A, Livingstone S, Charlton-Menys V, Bao W, Demicco DA, Preston GM, Deshmukh H, Tan K, Fuller JH. Colhoun HM, et al. Diabetes. 2011 Sep;60(9):2379-85. doi: 10.2337/db11-0291. Epub 2011 Jul 19. Diabetes. 2011. PMID: 21771973 Free PMC article.

2

Drug therapy for coronary heart disease: the Sheffield table.

Colhoun H, Fuller J. Colhoun H, et al. Lancet. 1997 Dec 20-27;350(9094):1853-4. doi: 10.1016/S0140-6736(05)63673-2. Lancet. 1997. PMID: 9428277 No abstract available.

3

Status report of lipid-lowering trials in diabetes.

Betteridge DJ, Colhoun H, Armitage J. Betteridge DJ, et al. Curr Opin Lipidol. 2000 Dec;11(6):621-6. doi: 10.1097/00041433-200012000-00009. Curr Opin Lipidol. 2000. PMID: 11086336

4

Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.

Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH. Colhoun HM, et al. Diabetes. 2002 Jun;51(6):1949-56. doi: 10.2337/diabetes.51.6.1949. Diabetes. 2002. PMID: 12031985

5

Activated factor XII levels and factor XII 46C>T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects.

Colhoun HM, Zito F, Norman Chan N, Rubens MB, Fuller JH, Humphries SE. Colhoun HM, et al. Atherosclerosis. 2002 Aug;163(2):363-9. doi: 10.1016/s0021-9150(02)00022-9. Atherosclerosis. 2002. PMID: 12052484

6

C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification.

Colhoun HM, Schalkwijk C, Rubens MB, Stehouwer CD. Colhoun HM, et al. Diabetes Care. 2002 Oct;25(10):1813-7. doi: 10.2337/diacare.25.10.1813. Diabetes Care. 2002. PMID: 12351483

7

Human cytomegalovirus seropositivity is associated with impaired vascular function.

Grahame-Clarke C, Chan NN, Andrew D, Ridgway GL, Betteridge DJ, Emery V, Colhoun HM, Vallance P. Grahame-Clarke C, et al. Among authors: colhoun hm. Circulation. 2003 Aug 12;108(6):678-83. doi: 10.1161/01.CIR.0000084505.54603.C7. Epub 2003 Aug 4. Circulation. 2003. PMID: 12900349

8

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH; CARDS investigators. Colhoun HM, et al. Lancet. 2004 Aug 21-27;364(9435):685-96. doi: 10.1016/S0140-6736(04)16895-5. Lancet. 2004. PMID: 15325833 Clinical Trial.

9

Treatment of lipid disorders in patients with diabetes.

Colhoun HM, Betteridge DJ. Colhoun HM, et al. Curr Treat Options Cardiovasc Med. 2006 Feb;8(1):37-45. doi: 10.1007/s11936-006-0024-8. Curr Treat Options Cardiovasc Med. 2006. PMID: 16401382

10

High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database.

Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. Soedamah-Muthu SS, et al. Among authors: colhoun hm. Diabetes Care. 2006 Apr;29(4):798-804. doi: 10.2337/diacare.29.04.06.dc05-1433. Diabetes Care. 2006. PMID: 16567818 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page